PRP treatment of the empty nose syndrome
Questo sito o gli strumenti terzi utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la "cookie policy" nella sezione "Altro" del sito.
Cliccando su Ok in questo banner o cliccando su un link, acconsenti all’uso dei cookie. Se vuoi saperne di più clicca qui e consulta l’Informativa
OK

 Regenerative medicine can cure even the empty nose syndrome (ENS)

The PRP was effective also in the stimulation of the nasal mucous atrophied

The use of platelet rich plasma (PRP) for the treatment of the empty nose syndrome (ENS) has the purpose to stimulate the regeneration of the nasal mucous.

The treatment is innovative (the use of platelet growth factors is now limited orthopedics and aesthetic medicine) and does not require hospitalization or anesthesia and is not subject to risk of intolerance or rejection as the PRP for the treatment of the empty nose syndrome is obtained directly from the blood of the patient (by filtration and centrifugation).

The empty nose syndrome describes a clinical situation due to excessive removal of the nasal mucosa and occurs especially after a too aggressive turbinectomy and is associated with various inconveniences as nasal dryness or difficulty in breathing night.

The treatment of ENS with PRP allows doctors to extend the techniques available (now using retreading materials such as Alloderm) and may give new hope to sufferers of this disease, which soon becomes debilitating.

Dr. Enrico Dondè - care atrophic rhinitis and empty nose syndrome with platelet growth factors in Italy - receives patients in Milano, and Torino ph. +3902860321 - enricodond@gmail.com -

 Regenerative medicine can cure even the empty nose syndrome (ENS)

The PRP was effective also in the stimulation of the nasal mucous atrophied

The use of platelet rich plasma (PRP) for the treatment of the empty nose syndrome (ENS) has the purpose to stimulate the regeneration of the nasal mucous.

The treatment is innovative (the use of platelet growth factors is now limited orthopedics and aesthetic medicine) and does not require hospitalization or anesthesia and is not subject to risk of intolerance or rejection as the PRP for the treatment of the empty nose syndrome is obtained directly from the blood of the patient (by filtration and centrifugation).

The empty nose syndrome describes a clinical situation due to excessive removal of the nasal mucosa and occurs especially after a too aggressive turbinectomy and is associated with various inconveniences as nasal dryness or difficulty in breathing night.

The treatment of ENS with PRP allows doctors to extend the techniques available (now using retreading materials such as Alloderm) and may give new hope to sufferers of this disease, which soon becomes debilitating.

Dr. Enrico Dondè - care atrophic rhinitis and empty nose syndrome with platelet growth factors in Italy - receives patients in Milano, and Torino ph. +3902860321 - enricodond@gmail.com -
Contatta il Dr. Enrico Dondè
Telefono/WhatsApp/Telegram
email
Oppure compila il form di contatto
Clicca "Non sono un robot"
Informativa sulla Privacy
Ho preso visione dell’informativa privacy e ne ho compreso il contenuto. Autorizzo il trattamento dei miei dati personali e sensibili nei termini di Legge.
Contatta il Dr. Enrico Dondè
Telefono/WhatsApp/Telegram
email
Oppure compila il form di contatto
Clicca "Non sono un robot"
Informativa sulla Privacy
Ho preso visione dell’informativa privacy e ne ho compreso il contenuto. Autorizzo il trattamento dei miei dati personali e sensibili nei termini di Legge.
Torna su